Characteristics | IOL without ACP n = 484 | IOL with ACP n = 763 | P-value* |
Sex |
|
| 0.86 |
Female | 265 (54.8%) | 422 (55.3%) |
|
Male | 219 (45.2%) | 341 (44.7%) |
|
Eye |
|
| 0.30 |
Left | 230 (47.5%) | 387 (50.7%) |
|
Right | 254 (52.5%) | 376 (49.3%) |
|
Anesthesia |
|
| 0.044 |
General | 1 (0.2%) | 13 (1.7%) |
|
Injection | 287 (59.3%) | 436 (57.1%) |
|
Topical | 196 (40.5%) | 313 (41.0%) |
|
Cataract severity score |
|
| 0.020 |
0 | 66 (13.6%) | 70 (9.2%) |
|
1, 1.5 | 111 (22.9%) | 154 (20.2%) |
|
2, 2.5 | 148 (30.6%) | 281 (36.8%) |
|
3, 3.5, 4 | 159 (32.9%) | 258 (33.8%) |
|
Intraocular lens type |
|
| <0.0001 |
Loop haptic | 177 (36.6%) | 148 (19.4%) |
|
Plate haptic | 307 (63.4%) | 615 (80.6%) |
|
Intraocular lens |
|
| <0.0001 |
AA | 299 (61.8%) | 614 (80.5%) |
|
MA | 59 (12.2%) | 90 (11.8%) |
|
SI | 93 (19.2%) | 4 (0.5%) |
|
Other | 33 (6.8%) | 55 (7.2%) |
|
Age (years) |
|
| 0.062 |
Mean ± SD | 70.4 ± 12.4 | 71.3 ± 12.0 |
|
Median (range) | 72.5 (19 to 94) | 74 (21 to 93) |
|
Duration of follow-up (months) |
|
| 0.009 |
Mean ± SD | 48.5 ± 46.7 | 41.2 ± 41.1 |
|
Median (range) | 35.4 (0.3 to 220.4) | 28.1 (0.0 to 164.7) |
|